Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Similar or more harmful | Less harmful | Don't know |
|---|---|---|---|
| 2013 | 12.9% | 72.6% | 14.5% |
| 2014 | 19.6% | 66% | 14.4% |
| 2015 | 24.6% | 65.5% | 9.9% |
| 2016 | 25.7% | 62.3% | 12% |
| 2017 | 28% | 61.3% | 10.7% |
| 2018 | 31.1% | 53% | 15.9% |
| 2019 | 33.8% | 50.1% | 16.2% |
| 2020 | 40.9% | 41.5% | 17.5% |
| 2021 | 37.2% | 42.5% | 20.4% |
| 2022 | 40.9% | 42.1% | 16.9% |
| 2023 | 54% | 33% | 13% |
| 2024 | 58% | 31% | 11% |
| 2025 | 63% | 27% | 10% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
July 2025
More information
Region
United Kingdom (Great Britain)
Survey time period
2013 to 2025
Number of respondents
2,533*
Age group
11-17 years
Method of interview
Online survey
Supplementary notes
* n(2013)= 1,190; n(2014)= 1,483; n(2015)= 1,700; n(2016)= 1,607; n(2017)=1,968; n(2018)= 1,687; n(2019)=1,863; n(2020)=1,909, n(2021) = 1,905, n(2022) = 1,916, n(2023) = 1,917, n(2024) = 2,596
Citation formats
